Related Experiment Video
Updated: Aug 26, 2026

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care
Published on: February 16, 2015
USP5 stabilizes RSK1 and promotes temozolomide resistance in glioblastoma
Xueping Shi1, Ruting Wei2, Mingliang Ren3
1Department of Neurosurgery, The Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou Province, 550001, China; Department of Neurosurgery, Daping Hospital, Army Medical University, Chongqing, China.
Abstract:
Temozolomide (TMZ) resistance is a major hurdle in glioblastoma multiforme (GBM). RSK1 is associated with glioma malignancy, but its role in resistance remains unclear. We show that RSK1 is upregulated in TMZ-resistant (TR) cells and tissues, and silencing it restores TMZ sensitivity in vitro and in vivo. USP5, a deubiquitinase, stabilizes RSK1 and is overexpressed in TR-GBM. Mechanistically, USP5 directly interacts with RSK1 and removes K48-linked ubiquitin chains, thereby increasing RSK1 levels and conferring resistance; USP5 knockdown has the opposite effect. WP1130, a broad-spectrum deubiquitinase inhibitor that suppresses USP5 activity, effectively promotes RSK1 degradation and reverses TMZ resistance. In clinical samples, USP5 levels correlate with RSK1, and high expression of either predicts poor prognosis in TMZ-treated patients. Overall, these findings highlight the USP5/RSK1 axis in chemoresistance and suggest that targeting this pathway may benefit patients who are resistant to TMZ.
More Related Videos
09:36Live-Cell Imaging Assays to Study Glioblastoma Brain Tumor Stem Cell Migration and Invasion
Published on: August 29, 2018
10:13Modeling Astrocytoma Pathogenesis In Vitro and In Vivo Using Cortical Astrocytes or Neural Stem Cells from Conditional, Genetically Engineered Mice
Published on: August 12, 2014
Related Concept Videos
Abnormal Proliferation
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Drugs that Stabilize Microtubules